Jerome D Jabbour - Net Worth and Insider Trading

Jerome D Jabbour Net Worth

The estimated net worth of Jerome D Jabbour is at least $134,638 dollars as of 2024-05-22. Jerome D Jabbour is the President and CEO of Matinas BioPharma Holdings Inc and owns about 799,511 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $134,638. Details can be seen in Jerome D Jabbour's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jerome D Jabbour has not made any transactions after 2020-03-17 and currently still holds the listed stock(s).

Transaction Summary of Jerome D Jabbour

To

Jerome D Jabbour Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jerome D Jabbour owns 1 companies in total, including Matinas BioPharma Holdings Inc (MTNB) .

Click here to see the complete history of Jerome D Jabbour’s form 4 insider trades.

Insider Ownership Summary of Jerome D Jabbour

Ticker Comapny Transaction Date Type of Owner
MTNB Matinas BioPharma Holdings Inc 2020-03-17 director & Chief Executive Officer

Jerome D Jabbour Latest Holdings Summary

Jerome D Jabbour currently owns a total of 1 stock. Jerome D Jabbour owns 799,511 shares of Matinas BioPharma Holdings Inc (MTNB) as of March 17, 2020, with a value of $134,638.

Latest Holdings of Jerome D Jabbour

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MTNB Matinas BioPharma Holdings Inc 2020-03-17 799,511 0.17 134,638

Holding Weightings of Jerome D Jabbour


Jerome D Jabbour Form 4 Trading Tracker

According to the SEC Form 4 filings, Jerome D Jabbour has made a total of 3 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 10,000 shares on March 17, 2020, which cost Jerome D Jabbour around $6,500.

Insider Trading History of Jerome D Jabbour

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jerome D Jabbour Trading Performance

GuruFocus tracks the stock performance after each of Jerome D Jabbour's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jerome D Jabbour is 30.49%. GuruFocus also compares Jerome D Jabbour's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jerome D Jabbour within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jerome D Jabbour's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jerome D Jabbour

Average Return

Average return per transaction

Outperforming Transactions

3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.11
Relative Return to S&P 500(%) -8.16

Jerome D Jabbour Ownership Network

Ownership Network List of Jerome D Jabbour

No Data

Ownership Network Relation of Jerome D Jabbour


Jerome D Jabbour Owned Company Details

What does Matinas BioPharma Holdings Inc do?

Who are the key executives at Matinas BioPharma Holdings Inc?

Jerome D Jabbour is the director & Chief Executive Officer of Matinas BioPharma Holdings Inc. Other key executives at Matinas BioPharma Holdings Inc include Chief Technology Officer Liu Hui , Chief Business Officer Thomas Hoover , and Chief Financial Officer Keith A Kucinski .

Matinas BioPharma Holdings Inc (MTNB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Matinas BioPharma Holdings Inc (MTNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Matinas BioPharma Holdings Inc (MTNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Matinas BioPharma Holdings Inc (MTNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Matinas BioPharma Holdings Inc Insider Transactions

No Available Data

Jerome D Jabbour Mailing Address

Above is the net worth, insider trading, and ownership report for Jerome D Jabbour. You might contact Jerome D Jabbour via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206, Suite 302, Bedminster Nj 07921.

Discussions on Jerome D Jabbour

No discussions yet.